Cargando…

Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms

BACKGROUND: Pharmacological synergisms are an attractive anticancer strategy. However, with more than 5000 approved-drugs and compounds in clinical development, identifying synergistic treatments represents a major challenge. METHODS: High-throughput screening was combined with target deconvolution...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ariey-Bonnet, Jérémy, Berges, Raphael, Montero, Marie-Pierre, Mouysset, Baptiste, Piris, Patricia, Muller, Kevin, Pinna, Guillaume, Failes, Tim W., Arndt, Greg M., Morando, Philippe, Baeza-Kallee, Nathalie, Colin, Carole, Chinot, Olivier, Braguer, Diane, Morelli, Xavier, André, Nicolas, Carré, Manon, Tabouret, Emeline, Figarella-Branger, Dominique, Le Grand, Marion, Pasquier, Eddy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433015/ https://www.ncbi.nlm.nih.gov/pubmed/37572644 http://dx.doi.org/10.1016/j.ebiom.2023.104752

Ejemplares similares

End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo
por: Berges, Raphael, et al.
Publicado: (2014)

Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma
por: Berges, Raphael, et al.
Publicado: (2018)

Molecular heterogeneity of glioblastomas: does location matter?
por: Denicolaï, Emilie, et al.
Publicado: (2015)

Deciphering the Action of Neuraminidase in Glioblastoma Models
por: Baeza-Kallee, Nathalie, et al.
Publicado: (2023)

Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo
por: Denicolaï, Emilie, et al.
Publicado: (2014)

A2B5 Expression in Central Nervous System and Gliomas
por: Figarella-Branger, Dominique, et al.
Publicado: (2022)

Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data
por: Sidorov, Pavel, et al.
Publicado: (2019)

Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells
por: Baeza-Kallee, Nathalie, et al.
Publicado: (2019)

Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152
por: Tchoghandjian, A, et al.
Publicado: (2016)

Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma
por: Mercurio, Sandy, et al.
Publicado: (2013)

Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression
por: Le Grand, Marion, et al.
Publicado: (2017)

Differential scanning calorimetry of plasma in glioblastoma: toward a new prognostic / monitoring tool
por: Tsvetkov, Philipp O., et al.
Publicado: (2018)

Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway
por: Tabouret, Emeline, et al.
Publicado: (2015)

EB1-dependent long survival of glioblastoma-grafted mice with the oral tubulin-binder BAL101553 is associated with inhibition of tumor angiogenesis
por: Bergès, Raphaël, et al.
Publicado: (2020)

Brief CommunicationCirculating tumor DNA is present in the most aggressive meningiomas
por: Graillon, Thomas, et al.
Publicado: (2020)

An AI-Powered Blood Test to Detect Cancer Using NanoDSF
por: Tsvetkov, Philipp O., et al.
Publicado: (2021)

Metronomics: Intrinsic Anakoinosis Modulator?
por: Nicolas, André, et al.
Publicado: (2018)

In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor
por: Ariey‐Bonnet, Jeremy, et al.
Publicado: (2020)

ROS-mediated EB1 phosphorylation through Akt/GSK3β pathway: implication in cancer cell response to microtubule-targeting agents
por: Grand, Marion Le, et al.
Publicado: (2014)

Negative Survival Impact of High Radiation Doses to Neural Stem Cells Niches in an IDH-Wild-Type Glioblastoma Population
por: Muracciole, Xavier, et al.
Publicado: (2018)

High-grade glioma in elderly patients: can the oncogeriatrician help?
por: Tabouret, Emeline, et al.
Publicado: (2013)

Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
por: Appay, Romain, et al.
Publicado: (2018)

Association of carcinoid tumor and low grade glioma
por: Tabouret, Emeline, et al.
Publicado: (2012)

Polysialic Acid Neural Cell Adhesion Molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines
por: Amoureux, Marie-Claude, et al.
Publicado: (2010)

Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study
por: Jiguet-Jiglaire, Carine, et al.
Publicado: (2022)

Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab–irinotecan in children with low‐grade glioma?
por: Heng, Marie Amélie, et al.
Publicado: (2016)

Coping strategies and quality of life: a longitudinal study of high-grade glioma patient-caregiver dyads
por: Baumstarck, Karine, et al.
Publicado: (2018)

Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer
por: Bondarenko, Maryna, et al.
Publicado: (2021)

Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastoma
por: Rossi, Maïlys, et al.
Publicado: (2022)

Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells
por: Lamballe, Fabienne, et al.
Publicado: (2016)

Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitro
por: Graillon, Thomas, et al.
Publicado: (2017)

Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH-Mutant Gliomas: A French POLA Network Study
por: Montégut, Coline, et al.
Publicado: (2022)

Conditional generation of free radicals by selective activation of alkoxyamines: towards more effective and less toxic targeting of brain tumors
por: Piris, Patricia, et al.
Publicado: (2023)

Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression
por: Petrirena, Gregorio J., et al.
Publicado: (2018)

Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells
por: Pasquier, Eddy, et al.
Publicado: (2012)

Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment
por: Pasquier, Eddy, et al.
Publicado: (2011)

Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
por: Picart, Thiébaud, et al.
Publicado: (2021)

Editorial: Novel diagnostic and therapeutic strategies in the management of cerebral gliomas
por: Caffo, Maria, et al.
Publicado: (2023)

Anti-Migratory Effect of Vinflunine in Endothelial and Glioblastoma Cells Is Associated with Changes in EB1 C-Terminal Detyrosinated/Tyrosinated Status
por: Rovini, Amandine, et al.
Publicado: (2013)

Plasma nanoDSF Denaturation Profile at Baseline Is Predictive of Glioblastoma EGFR Status
por: Eyraud, Rémi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u55ig3buvvabljmpp16q6e66r5